- Report
- October 2024
- 199 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- January 2025
- 180 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- August 2024
- 182 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2025
- 270 Pages
Global
From €4789EUR$4,995USD£4,001GBP
- Report
- June 2024
- 132 Pages
North America
From €3835EUR$4,000USD£3,204GBP
- Report
- October 2023
- 113 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- September 2023
- 120 Pages
North America
From €5704EUR$5,950USD£4,766GBP
- Report
- January 2023
- 280 Pages
Global
From €3422EUR$3,570USD£2,860GBP
- Book
- February 2025
- 160 Pages
- Book
- June 2022
- 1100 Pages

Pyelonephritis is a type of urinary tract infection (UTI) that affects the kidneys. It is caused by bacteria that enter the urinary tract and travel up to the kidneys. Symptoms of pyelonephritis include fever, chills, nausea, vomiting, and pain in the lower back or side. Treatment typically involves antibiotics and may require hospitalization.
Pyelonephritis is a major concern in the field of urology and nephrology. Urologists specialize in the diagnosis and treatment of diseases of the urinary tract, while nephrologists specialize in the diagnosis and treatment of diseases of the kidneys. Both specialties are involved in the diagnosis and treatment of pyelonephritis.
The pyelonephritis market includes a variety of companies that develop and market products for the diagnosis and treatment of the condition. These include pharmaceutical companies that develop and market antibiotics, medical device companies that develop and market imaging and diagnostic equipment, and biotechnology companies that develop and market diagnostic tests.
Examples of companies in the pyelonephritis market include Pfizer, Merck, Johnson & Johnson, Siemens Healthineers, and Abbott Laboratories. Show Less Read more